iQIYI (IQ.US) Latest News & Headlines | Longbridge

Weekly Recap | iQIYI +8.23%, most brokers rate it buy
Weekly Review·Sep 12 at 06:08 AM
- iQiyi shares rose 8.23% over four trading days to close at 0.9524 USD, outperforming the S&P 500 by 9.03 percentage points alongside a 31% increase in daily trading volume. - The company launched a global AI creator challenge on September 10, 2025, to promote professional AI film production and entered Chinese stock AI application narratives. - Among 20 covering institutions, 7 rated it a buy and the consensus target price reached 1.397 USD, while differing target ranges and low valuation multiples highlighted market divergence.
IQ+6.48%
Weekly Recap | iQIYI -4.35%, most brokers rate it buy
Weekly Review·Sep 5 at 07:08 AM
- iQiyi (IQ.US) experienced a cumulative decline of 4.35 % this week, closing at 0.88 USD and underperforming the S&P 500. - Despite the weak price performance, a consensus of 20 institutions maintains a buy rating with a target price of approximately 1.397 USD, indicating a potential upside of 58.75 %. - Future movements will depend on upcoming macroeconomic data releases and whether the stock can establish support between 0.86 and 0.88 USD.
IQ+6.48%
Weekly Recap | iQIYI -12.8%, near 60-day range low
Weekly Review·Aug 29 at 05:51 AM
- iQIYI accumulated a decline of 12.8 % this week, closing at 0.92 USD and hitting a 60-day low. - A total of 20 institutions covered the company with a consensus rating of buy and an average target price of 1.40 USD. - Investors need to watch key upcoming U.S. macroeconomic data releases scheduled for next week.
IQ+6.48%
Weekly Recap | iQIYI -21.85%, Q2 miss triggers broad sell-off
Weekly Review·Aug 22 at 05:09 AM
- iQIYI accumulated a weekly decline of 21.85 % to close at 1.055 USD, significantly underperforming the S&P 500. - The sharp sell-off was triggered by the Q2 2026 financial report, which showed a 5 % year-on-year drop in revenue to 6.29 billion RMB and an expanded net loss of 287.5 million RMB. - Despite the weak earnings and negative market reaction, institutional consensus remains a buy with a target price of approximately 1.397 USD.
IQ+6.48%